Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1997-06-10
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548200, C07D22710, A61K 3140
Patent
active
056376022
DESCRIPTION:
BRIEF SUMMARY
DESCRIPTION OF THE INVENTION
The present invention relates to derivatives of formula: ##STR2## their salts, their preparation and the medications containing them.
In formula (I), sulphur atom, R.sub.1 denotes a pyridyl radical optionally substituted by one or more alkyl radicals, furyl optionally substituted by one or more alkyl radicals, thienyl optionally substituted by one or more alkyl radicals, quinolyl optionally substituted by one or more alkyl radicals, naphthyl optionally substituted by one or more alkyl radicals, indolyl optionally substituted by one or more alkyl radicals or phenyl optionally substituted by one or more substituents chosen from halogen atoms and alkyl, alkoxy, hydroxyl, nitro, amino, monoalkylamino, dialkylamino, alkoxycarbonyl, --CO--NR.sub.7 R.sub.8, --NH--CO--CH.sub.3, trifluoromethyl or trifluoromethoxy radicals, and R.sub.5 denotes a hydrogen atom, R.sub.5 denotes a phenyl radical, hydrogen atom, cycloalkylalkoxycarbonyl, --CONR.sub.9 R.sub.10 or phenyl radical optionally substituted by one or more substituents chosen from alkyl, alkoxy or hydroxyl radicals, substituted by one or more substituents chosen from the radicals -alk-SO.sub.2 H, --SO.sub.2 --NH--CO--R.sub.11, --B(OH).sub.2, --SO.sub.2 --NH--SO.sub.2 --R.sub.11, --CO--NH--CO--R.sub.11, --CO--NH--SO.sub.2 --R.sub.11, --C(NH.sub.2).dbd.NOH, --SO.sub.2 --NH--R.sub.12, --CO--NH--R.sub.12, ##STR3## and optionally by one or more substituents chosen from halogen atoms and alkyl, alkoxy, alkylthio, trifluoromethyl, carboxyl, alkoxycarbonyl, hydroxyl, nitro, amino, acyl, cyano, sulphamoyl, carbamoyl, hydroxyiminoalkyl, alkoxyiminoalkyl, hydroxyaminocarbonyl, alkoxyaminocarbonyl, 5-tetrazolyl, 5-tetrazolylalkyl, trifluoromethylsulphonamido, alkylsulphinyl, mono- or polyhydroxyalkyl, sulpho, -alk-O--CO-alk, -alk-COOX, -alk-O-alk, -alk'-COOX, --O-alk-COOX, --CH.dbd.CH--COOX, --CO--COOX, -alk-SO.sub.3 H (in salt form), --CH.dbd.CH-alk', --C(.dbd.NOH)--COOX, --S-alk-COOX, --SO-alk-COOX, --SO.sub.2 -alk-COOX, --O--CH.sub.2 -alk'-COOX, --CX.dbd.N--O-alk-COOX, -alk-N(OH)--CO-alk or 2,2-dimethyl-4,6-dioxo-1,3-dioxan-5-yl radicals, optionally substituted by one or more substituents chosen from halogen atoms and alkyl, alkoxy and alkylthio radicals, substituted by one or more substituents chosen from halogen atoms and alkyl, alkoxy and alkylthio radicals, are attached form a saturated or unsaturated mono- or polycyclic heterocyclic ring containing 4 to 9 carbon atoms and one or more heteroatoms (O, N) and optionally substituted by one or more alkyl radicals, phenylalkyl or phenyl radical optionally substituted by one or more substituents chosen from halogen atoms and alkyl, alkoxy and alkylthio radicals, phenyl radical optionally substituted by one or more substituents chosen from halogen atoms and alkyl, alkoxy and alkylthio radicals, are attached form a saturated or unsaturated mono- or polycyclic heterocyclic ring containing 4 to 9 carbon atoms and one or more heteroatoms (O, N, S) and optionally substituted by one or more alkyl radicals, optionally substituted by one or more substituents chosen from cyano, alkoxy, nitro and amino radicals and halogen atoms, radical.
In the above definitions and those which will be cited below, unless stated otherwise, the alkyl, alkylene and alkoxy radicals and the alkyl, alkylene and alkoxy parts contain 1 to 4 carbon atoms as a straight or branched chain, the acyl radicals or parts contain 2 to 4 carbon atoms and the cycloalkyl radicals and parts contain 3 to 6 carbon atoms.
When R.sub.7 and R.sub.8 with the nitrogen atom to which they are attached form a heterocyclic ring, the latter is preferably a piperidino ring optionally substituted by one or more alkyl radicals or a 1,2,3,4-tetrahydroquinoline ring.
When R.sub.9 and R.sub.10 with the nitrogen atom to which they are attached form a heterocyclic ring, the latter is preferably a piperidino, 1-perhydroazepinyl, 1,2,3,6-tetrahydro-1-pyridyl, 1,2,3,4-tetrahydro-1-quinolyl, 1-pyrrolidinyl, 1,2,3,4-tetrahydro-2-isoquinolyl, thiomorpholino or 1-in
Capet Marc
Dubroeucq Marie-Christine
Manfre Franco
Martin Jean-Paul
Gerstl Robert
Rhone-Poulenc Rorer S.A.
LandOfFree
Pyrrolidine and thiazolidine derivatives, their preparation and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrrolidine and thiazolidine derivatives, their preparation and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrrolidine and thiazolidine derivatives, their preparation and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-764875